WNS Earnings

WNS reported its earnings on 2025-10-16, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.92 by 0%. The stock experienced a 0.1% price change on the earnings day and a 0.1% change over the next five days, reflecting market reactions to the results.

Following WNS's earnings announcement on 2025-10-16, the stock price moved by 0.1% on the day of the release. Over the subsequent five days, it saw a 0.1% change. Historically, WNS's stock price tends to shift by an average of -0.32% in the 10 days leading up to earnings and 0.09% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate WNS's annual revenue to reach 340.32M, while the EPS is projected at 1.08. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between WNS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, WNS's stock price typically moves by -0.32% in the 10 days before its earnings and 0.09% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.08 and revenue of 340.32M.

The earnings call revealed several concerns: declining revenue and high attrition rates, which could affect operational stability. Despite positive adjusted net income and EPS, the revenue guidance for fiscal 2025 is weak, with a projected decline. The Q&A section highlighted client ramp-downs and productivity challenges, further impacting growth outlook. Although share repurchases were executed, they may not offset the negative sentiment from revenue decline and attrition issues. Given the market cap of $2.36 billion, the stock is likely to experience a negative reaction, falling between -2% to -8% over the next two weeks.